International Clinical Trial: Multicenter Clinical Study and Exploration of Key Mechanisms of Berberine in Preventing Postoperative Recurrence of Colorectal Cancer

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117441) titled 'Multicenter Clinical Study and Exploration of Key Mechanisms of Berberine in Preventing Postoperative Recurrence of Colorectal Cancer' on Jan. 23.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The Second Affiliated Hospital of Zhejiang Chinese Medical University

Condition: Colorectal Cancer

Intervention: Trial group:Oral administration of berberine will be initiated simultaneously with postoperative chemotherapy (the chemotherapy regimen is formulated in accordance with the 2025 CSCO Guidelines for Colorectal Cancer), with the specific dosage as follows: 3 capsules (0.1 g per caps...